Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.6.4.1 (myosin ATPase)
 1,140 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The effects of Cd2+ on Ca2+-sensitive myosin ATPase activity were examined. In the absence of Ca2+, the Ca2+-dependent myosin ATPase activity was enhanced by Cd2+ to the same extent as with Ca2+ at concentrations ranging from 10(-6) to 10(-3) M. At 10(-2) M, however, no activation was observed. Zn2+, Co2+, and Sr2+ also activated the myosin ATPase. Sr2+ and Co2+ were less effective. Hg2+, Cr3+, and Cu2+ were essentially inactive. In the presence of below 10(-3) M Ca2+, the increase in the enzyme activity observed on the addition of Cd2+ was in addition to that caused by Ca2+ alone. The ability of metal ions to activate myosin ATPase was compared with that to activate calmodulin-dependent cAMP phosphodiesterase. The activating effects of the metal ions tested were in the order of Ca2+ greater than Cd2+ greater than Zn2+ greater than Co2+ greater than Sr2+ for Ca2+-sensitive myosin ATPase and Ca2+ greater than Cd2+ greater than Sr2+ greater than Zn2+ greater than Hg2+ greater than Co2+ for cAMP phosphodiesterase. Cd2+ activated both enzyme activities most efficiently among the metal ions tested except Ca2+. These results indicate that Cd2+ is able to substitute for Ca2+ in the case of Ca2+ dependent enzymes, regardless of whether or not calmodulin participates in the activating process.
 ...
PMID:Enhancement of Ca2+-sensitive myosin ATPase activity by cadmium. 282 3

Rho family GTPases are important regulators of neuronal morphology, but the proteins directly controlling their activity in neurons are still poorly defined. We report the identification of myr 7, a novel unconventional myosin IX-RhoGAP expressed in rat brain. Myr 7 is a multidomain protein related to myr 5, the first class IX myosin to be characterized. It exhibits a myosin head domain with an N-terminal extension and a large insertion at loop 2, an actin contact site and regulator of myosin ATPase rate. The myosin head domain is followed by a neck domain consisting of six unevenly spaced consecutive IQ motifs representing light chain binding sites. The tail domain contains a C6H2-zinc binding motif and a region that specifically stimulates the GTPase-activity of Rho followed by a short stretch predicted to adopt a coiled-coil structure. Five alternatively spliced regions, one in the 5'-noncoding region, two in the myosin head and two in the tail domain, were noted. Analysis of myr 7 and myr 5 expression in different tissues revealed that myr 7 is expressed at high levels in developing and adult brain tissue whereas myr 5 is expressed only at moderate levels in embryonic brain tissue and at even further reduced levels in adult brain tissue. Myr 5 is, however, highly expressed in lung, liver, spleen and testis. Myr 7 is expressed in all brain regions and is localized in the cytoplasm of cell bodies, dendrites and axons. Myr 5 exhibits an overlapping, but not identical cellular distribution. Finally, a myr 7 fusion protein encompassing the GAP domain specifically activates the GTPase-activity of Rho in vitro, and overexpression of myr 7 in HtTA1-HeLa cells leads to inactivation of Rho in vivo. These results are compatible with a role for myr 7 (and myr 5) in regulating Rho activity in neurons and hence in regulating neuronal morphology and function.
 ...
PMID:Myr 7 is a novel myosin IX-RhoGAP expressed in rat brain. 981 51